SGAM
TEVA icon

Steinberg Global Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Steinberg Global Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-25,618
Closed -$451K – 240
2017
Q3 		$451K Buy
25,618
+543
+2% +$12.2K 0.07% 180
2017
Q2 		$833K Sell
25,075
-2,502
-9% -$77.4K 0.13% 131
2017
Q1 		$885K Buy
27,577
+3,234
+13% +$110K 0.14% 123
2016
Q4 		$882K Sell
24,343
-3,858
-14% -$154K 0.15% 112
2016
Q3 		$1.3M Sell
28,201
-97
-0.3% -$5.06K 0.22% 87
2016
Q2 		$1.42M Sell
28,298
-257
-0.9% -$13.7K 0.25% 79
2016
Q1 		$1.53M Buy
28,555
+11,339
+66% +$665K 0.29% 68
2015
Q4 		$1.13M Sell
17,216
-188
-1% -$11.6K 0.22% 87
2015
Q3 		$982K Buy
17,404
+749
+4% +$48.6K 0.19% 93
2015
Q2 		$984K Sell
16,655
-5,802
-26% -$358K 0.19% 93
2015
Q1 		$1.4M Buy
22,457
+6,776
+43% +$394K 0.28% 72
2014
Q4 		$902K Buy
15,681
+412
+3% +$23K 0.19% 85
2014
Q3 		$820K Buy
15,269
+251
+2% +$13.3K 0.19% 92
2014
Q2 		$787K Buy
15,018
+554
+4% +$28.3K 0.18% 93
2014
Q1 		$764K Sell
14,464
-15
-0.1% -$693 0.19% 92
2013
Q4 		$580K Sell
14,479
-8,172
-36% -$322K 0.12% 117
2013
Q3 		$856K Buy
22,651
+1,050
+5% +$41K 0.19% 89
2013
Q2 		$847K Buy
+21,601
New +$841K 0.22% 84

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

Steinberg Global Asset Management's TEVA Position: Q4 2017 in Review

Steinberg Global Asset Management sold out of Teva Pharmaceuticals (TEVA) in Q4 2017, closing a stake of 25,618 shares — an estimated $451K sold.

Steinberg Global Asset Management first reported a position in TEVA in Q2 2013 and held it in 18 quarters. The position peaked at $1.53M in Q1 2016. 507 funds tracked by Wall St. Rank hold TEVA as of Q4 2017.

  • Steinberg Global Asset Management reported no remaining Teva Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Steinberg Global Asset Management sold 25,618 Teva Pharmaceuticals shares in Q4 2017, an estimated $451K.
  • Steinberg Global Asset Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 18 quarters.
  • Steinberg Global Asset Management's Teva Pharmaceuticals position peaked at $1.53M in Q1 2016.
  • 507 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2017.

Based on Steinberg Global Asset Management's 13F filing for Q4 2017, filed 2 Feb 2018.